Showing results (11-20 of 125) with videos related to

Sort By:
Pageof 13
Biochemistry|August 27, 1991
Raman spectroscopic studies of model human pulmonary surfactant systems: phospholipid interactions with peptide paradigms for the surfactant protein SP-BJ S Vincent, S D Revak, C G Cochrane, et al.
The Journal of Clinical Investigation|September 1, 1974
Structural changes accompanying enzymatic activation of human Hageman factorS D Revak, C G Cochrane, A R Johnston, et al.
The Journal of Experimental Medicine|March 1, 1978
Surface and fluid phase activities of two forms of activated Hageman factor produced during contact activation of plasmaS D Revak, C G Cochrane, B N Bouma, et al.
The Journal of Burn Care & Rehabilitation|November 1, 1987
Biochemical events associated with pulmonary failure in shock and traumaI U Schraufstätter, P A Hyslop, J Jackson, et al.
The Journal of Clinical Investigation|October 1, 1972
The interaction of Hageman factor and immune complexesC G Cochrane, K D Wuepper, B S Aiken, et al.
Advances in Experimental Medicine and Biology|January 1, 1979
Activation of human Hageman factor by a leukocytic proteaseH H Newball, S D Revak, C G Cochrane, et al.
The Journal of Clinical Investigation|March 1, 1988
Use of human surfactant low molecular weight apoproteins in the reconstitution of surfactant biologic activityS D Revak, T A Merritt, E Degryse, et al.
Pediatric Research|April 1, 1996
Efficacy of synthetic peptide-containing surfactant in the treatment of respiratory distress syndrome in preterm infant rhesus monkeysS D Revak, T A Merritt, C G Cochrane, et al.
The Journal of Clinical Investigation|September 1, 1985
Experimental pulmonary inflammatory injury in the monkeyS D Revak, C L Rice, I U Schraufstätter, et al.
Pediatric Research|May 1, 1991
The use of synthetic peptides in the formation of biophysically and biologically active pulmonary surfactantsS D Revak, T A Merritt, M Hallman, et al.
Pageof 13